0 items USD 0.00Search
Your search for "prostate cancer" gave back 8313 results.
Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Prostate cancer is cancer that occurs in the prostate. The “Prostate Cancer Industry Forecast” looks at past sales and reviews total world Prostate...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The “Prostate Cancer Biomarker Industry...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Prostate Cancer Diagnostics and Therapy Market The global Prostate Cancer Diagnostics and Therapy market is...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The “Prostate...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Prostate Cancer Drugs Industry Forecast” looks at past sales and reviews total world Prostate Cancer Drugs sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The “Prostate Cancer Therapeutics Industry Forecast” looks at past sales and reviews total world Prostate Cancer Therapeutics sales in 2022,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Prostate Cancer Vaccines Industry Forecast” looks at past sales and reviews total world Prostate Cancer Vaccines sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Prostate Cancer PARP Inhibitor Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
May 2023
Price: USD 4,480.00
